Home › Gilead leads rivals in race to cure hepatitis C
 

Keywords :   


Gilead leads rivals in race to cure hepatitis C

2014-03-03 10:02:11| Biotech - Topix.net

Gilead Sciences' Sovaldi can cure as many as 90 percent of hepatitis C patients in 12 to 24 weeks.

Tags: leads race cure hepatitis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »